These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 7769799

  • 1. Renal and systemic hemodynamic effects of ibopamine in patients with mild to moderate congestive heart failure.
    Lieverse AG, van Veldhuisen DJ, Smit AJ, Zijlstra JG, Meijer S, Reitsma WD, Lie KI, Girbes AR.
    J Cardiovasc Pharmacol; 1995 Mar; 25(3):361-7. PubMed ID: 7769799
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of ibopamine on renal haemodynamics in patients with severe congestive heart failure.
    Girbes AR, Kalisvaart CJ, Van Veldhuisen DJ, Tan ET, Smit AJ, Reitsma WD, Pasteuning WH.
    Eur Heart J; 1993 Feb; 14(2):279-83. PubMed ID: 8095455
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT).
    van Veldhuisen DJ, Man in 't Veld AJ, Dunselman PH, Lok DJ, Dohmen HJ, Poortermans JC, Withagen AJ, Pasteuning WH, Brouwer J, Lie KI.
    J Am Coll Cardiol; 1993 Nov 15; 22(6):1564-73. PubMed ID: 7901256
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
    Dei Cas L, Metra M, Nodari S, Visioli O.
    J Cardiovasc Pharmacol; 1989 Nov 15; 14 Suppl 8():S111-7. PubMed ID: 2483436
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
    Sannia L, Ibba GV, Castellaccio M, Dore L.
    Arzneimittelforschung; 1986 Feb 15; 36(2A):355-9. PubMed ID: 3707649
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. DIMT Study Group. Dutch Ibopamine Multicenter Trial.
    van Veldhuisen DJ, Brouwer J, Man in 't Veld AJ, Dunselman PH, Boomsma F, Lie KI.
    Am J Cardiol; 1995 Apr 15; 75(12):796-800. PubMed ID: 7717282
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group.
    Brouwer J, van Veldhuisen DJ, Man in 't Veld AJ, Dunselman PH, Boomsma F, Haaksma J, Lie KI.
    J Am Coll Cardiol; 1995 Oct 15; 26(4):983-90. PubMed ID: 7560628
    [Abstract] [Full Text] [Related]

  • 19. Electrophysiologic profile of ibopamine in patients with congestive heart failure and ventricular tachycardia and relation to its effects on hemodynamics and plasma catecholamines.
    Van Veldhuisen DJ, Crijns HJ, Girbes AR, Tobé TJ, Wiesfeld AC, Lie KI.
    Am J Cardiol; 1991 Nov 01; 68(11):1194-202. PubMed ID: 1683146
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.